MTaI welcomes govt’s move to restructure DPCO 2013

In a statement issued on May 10th, the Medical Technology Association of India (MTaI) has appreciated the union government's move to separate medical technology from the pharma industry

New Delhi: The Medical Technology Association of India (MTaI) in a statement has appreciated and welcomed the government’s move in treating medical devices differently from drugs, with the restructuring of the pharmaceutical sector-focused Drug Price Control Order (DPCO) 2013.
“MTaI has always urged the government to differentiate medical devices from pharmaceuticals as the medical device sector is still nascent, and unlike the chemistry-based Pharma sector, is based on engineering,” said the statement.
It also mentioned that MTaI is for greater patient access and proposes a systems-based approach and the revitalizing of the Medical Technology Advisory Board (MTAB) to judge matters pertaining to medical device pricing and arrive at decisions based on surgical therapy needs and solid clinical and health economics outcomes.